Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back


Sheikh Arslan Sehgal

University of Okara, Pakistan

Biography

Sheikh Arslan Sehgal  current study is aimed at exploring and identifying potential B- and T-cell epitopesthrough immunoinformatics approaches which help to design an effective vaccine againstdeadly SARS-CoV-2. In addition, the study is aimed at pointing out specific peptides from the coronaviral proteome, which have the ability to bind with major histocompatibility complex (MHC), one of the most crucial steps in vaccine designing. A multiepitope vaccine was also designed from different epitopes of coronavirus proteins joined by linkers and led by an adjuvant. Our investigations predicted epitopes and the reported molecules that may have the potential to inhibit the SARS-CoV-2 virus. These findings can be a step towards the development of a peptide-based vaccine or natural compound drug target against SARS-CoV-2.

Abstract

Abstract : Immunoinformatics and molecular docking studies predicted potential multi epitope based peptide vaccine and novel compounds against novel sars-cov-2 through virtual screening